Identification and prevalence of single-nucleotide polymorphisms in the P. falciparum genes pfcoronin and pfubp1 associated with artemisinin resistance in Ghana and Benin
Malaria remains a great public health concern, with an estimated 263 million cases and 597,000 estimated deaths in 2023. Artemisinin-based combination therapies (ACTs) are currently the first-line treatment for uncomplicated P. falciparum malaria in Sub-Saharan Africa (SSA), but the emergence of resistant parasites is threatening their efficacy. Single-nucleotide polymorphisms (SNPs) in the pfk13
